Hoe kunnen patiënt afgeleide modellen (bv. PDx en tumoroids) worden ontwikkelt om therapieën te individualiseren?
How to develop patient-derived models (i.e. PDx and tumoroids) to individualize therapies? One third of the population develops cancer sometime during their life, currently more than 100,000 people annually in The Netherlands. Still, about 40% of these patients will die from their disease within five years.